Fisher & Paykel Healthcare jumped after reporting strong FY26 earnings growth and a higher dividend.
Defence and industrial stocks gained momentum amid continued optimism around global military spending.
Agribusiness shares advanced as improving commodity sentiment and insider buying activity supported investor confidence.
The Australian share market saw strong buying interest across multiple sectors on Monday, with healthcare, defence, and agribusiness companies emerging among the day’s top-performing stocks. Investors rotated into companies viewed as benefiting from resilient earnings, structural growth trends, and improving sector sentiment.
Among the standout performers were Fisher & Paykel Healthcare Corporation Limited, Austal Limited, and GrainCorp Limited, all of which recorded notable gains during the trading session.
GrainCorp Limited (ASX: GNC) gained 3.8% to $5.085
Fisher & Paykel Healthcare Leads the Rally
Fisher & Paykel Healthcare Corporation Limited emerged as one of the strongest performers on the ASX after the company delivered robust FY26 financial results that reinforced investor confidence in its long-term growth outlook.
The healthcare company reported FY26 operating revenue of NZ$2.31 billion, up 14% from the previous year, while net profit after tax climbed 24% to NZ$468.5 million. Hospital product revenue rose 18% to NZ$1.51 billion, supported by strong global demand for respiratory and acute care products, while Homecare revenue increased 8% to NZ$802.7 million.
Investors also responded positively to the company’s improving margins and optimistic outlook for FY27. Gross margin expanded to 63.7%, while the company projected FY27 operating revenue between NZ$2.45 billion and NZ$2.57 billion, alongside expected net profit after tax of NZ$500 million to NZ$550 million.
The Board approved a final dividend of 33 cents per share, taking the total FY26 dividend to 52 cents per share, representing a 22% increase over the prior year. The dividend notice also confirmed a total distribution amount of NZ$0.38823529 per share.
Market optimism surrounding future hospital demand, product innovation, and long-term healthcare spending trends further supported buying activity in the stock.
Austal Gains on Defence Sector Optimism
Austal Limited also recorded strong gains as investors continued rotating into defence-related stocks amid expectations of elevated global military spending and growing geopolitical tensions.
The shipbuilder remains closely watched because of its exposure to naval defence programs in both Australia and the United States. Investors have increasingly viewed defence contractors as potential long-term beneficiaries of rising government expenditure on maritime security, military infrastructure, and defence capability upgrades. Sentiment towards the defence sector has strengthened in recent months, particularly as Indo-Pacific nations continue prioritising naval expansion and strategic security partnerships.
GrainCorp Advances as Commodity Sentiment Improves
GrainCorp Limited moved higher as investors responded positively to improving sentiment across agricultural and commodity-linked stocks. The agribusiness company remains heavily exposed to grain handling, storage, and export operations, making it sensitive to global crop conditions, export demand, and commodity price movements. Investor sentiment also appeared to strengthen following recent insider buying activity disclosed to the market.
A recent Change of Director’s Interest Notice showed that director Sarah Adam-Gedge purchased 7,350 fully paid ordinary shares on-market at $4.73 per share on 25 May 2026. Following the transaction, her total holding increased to 15,850 shares. Commodity-linked companies have also benefited from broader optimism surrounding global trade activity and supply chain normalisation, helping support buying interest in agribusiness stocks during the session. The strong gains across healthcare, defence, and agribusiness shares highlighted continued investor appetite for companies tied to structural growth themes, defensive earnings, and long-term industry demand despite mixed broader market conditions.
Note- All data presented is based on information available at the time of writing.
Disclaimer for Kapitales Research
The materials provided by Kapitales Research, including articles, news, data, reports, opinions, images, charts, and videos ("Content"), are intended for personal, non-commercial use only. The primary goal of this Content is to educate and inform readers. This Content is not meant to offer financial advice, nor does it include any recommendation or opinion that should be relied upon for making financial decisions. Certain Content on this platform may be sponsored or unsponsored, but it does not serve as a solicitation or endorsement to buy, sell, or hold any securities, nor does it encourage any specific investment activities. Kapitales Research is not authorized to provide investment advice, and we strongly advise users to seek guidance from a qualified financial professional, such as a financial advisor or stockbroker, before making any investment choices. Kapitales Research disclaims all liability for any direct, indirect, incidental, or consequential damages arising from the use of the Content, which is provided without any warranties. The opinions expressed by contributors or guests are their own and do not necessarily reflect the views of Kapitales Research. Media such as images or music used on this platform are either owned by Kapitales Research, sourced through paid subscriptions, or believed to be in the public domain. We have made reasonable efforts to credit sources where appropriate. Kapitales Research does not claim ownership of any third-party media unless explicitly stated otherwise.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au
x
Daily Dose of Buy, Sell & Hold recommendations before the market opens.
Start Your 7 Days Free Trial Now!
We use cookies to help us improve, promote, and protect our services.
By continuing to use this site, we assume you consent to this.
Read our
Privacy Policy
and
Terms & Conditions
Why Are These 3 ASX Stocks Suddenly in Focus?
Highlights:
The Australian share market saw strong buying interest across multiple sectors on Monday, with healthcare, defence, and agribusiness companies emerging among the day’s top-performing stocks. Investors rotated into companies viewed as benefiting from resilient earnings, structural growth trends, and improving sector sentiment.
Among the standout performers were Fisher & Paykel Healthcare Corporation Limited, Austal Limited, and GrainCorp Limited, all of which recorded notable gains during the trading session.
Stocks in Focus:
Fisher & Paykel Healthcare Leads the Rally
Fisher & Paykel Healthcare Corporation Limited emerged as one of the strongest performers on the ASX after the company delivered robust FY26 financial results that reinforced investor confidence in its long-term growth outlook.
The healthcare company reported FY26 operating revenue of NZ$2.31 billion, up 14% from the previous year, while net profit after tax climbed 24% to NZ$468.5 million. Hospital product revenue rose 18% to NZ$1.51 billion, supported by strong global demand for respiratory and acute care products, while Homecare revenue increased 8% to NZ$802.7 million.
Investors also responded positively to the company’s improving margins and optimistic outlook for FY27. Gross margin expanded to 63.7%, while the company projected FY27 operating revenue between NZ$2.45 billion and NZ$2.57 billion, alongside expected net profit after tax of NZ$500 million to NZ$550 million.
The Board approved a final dividend of 33 cents per share, taking the total FY26 dividend to 52 cents per share, representing a 22% increase over the prior year. The dividend notice also confirmed a total distribution amount of NZ$0.38823529 per share.
Market optimism surrounding future hospital demand, product innovation, and long-term healthcare spending trends further supported buying activity in the stock.
Austal Gains on Defence Sector Optimism
Austal Limited also recorded strong gains as investors continued rotating into defence-related stocks amid expectations of elevated global military spending and growing geopolitical tensions.
The shipbuilder remains closely watched because of its exposure to naval defence programs in both Australia and the United States. Investors have increasingly viewed defence contractors as potential long-term beneficiaries of rising government expenditure on maritime security, military infrastructure, and defence capability upgrades. Sentiment towards the defence sector has strengthened in recent months, particularly as Indo-Pacific nations continue prioritising naval expansion and strategic security partnerships.
GrainCorp Advances as Commodity Sentiment Improves
GrainCorp Limited moved higher as investors responded positively to improving sentiment across agricultural and commodity-linked stocks. The agribusiness company remains heavily exposed to grain handling, storage, and export operations, making it sensitive to global crop conditions, export demand, and commodity price movements. Investor sentiment also appeared to strengthen following recent insider buying activity disclosed to the market.
A recent Change of Director’s Interest Notice showed that director Sarah Adam-Gedge purchased 7,350 fully paid ordinary shares on-market at $4.73 per share on 25 May 2026. Following the transaction, her total holding increased to 15,850 shares. Commodity-linked companies have also benefited from broader optimism surrounding global trade activity and supply chain normalisation, helping support buying interest in agribusiness stocks during the session. The strong gains across healthcare, defence, and agribusiness shares highlighted continued investor appetite for companies tied to structural growth themes, defensive earnings, and long-term industry demand despite mixed broader market conditions.
Note- All data presented is based on information available at the time of writing.
Disclaimer for Kapitales Research
The materials provided by Kapitales Research, including articles, news, data, reports, opinions, images, charts, and videos ("Content"), are intended for personal, non-commercial use only. The primary goal of this Content is to educate and inform readers. This Content is not meant to offer financial advice, nor does it include any recommendation or opinion that should be relied upon for making financial decisions. Certain Content on this platform may be sponsored or unsponsored, but it does not serve as a solicitation or endorsement to buy, sell, or hold any securities, nor does it encourage any specific investment activities. Kapitales Research is not authorized to provide investment advice, and we strongly advise users to seek guidance from a qualified financial professional, such as a financial advisor or stockbroker, before making any investment choices. Kapitales Research disclaims all liability for any direct, indirect, incidental, or consequential damages arising from the use of the Content, which is provided without any warranties. The opinions expressed by contributors or guests are their own and do not necessarily reflect the views of Kapitales Research. Media such as images or music used on this platform are either owned by Kapitales Research, sourced through paid subscriptions, or believed to be in the public domain. We have made reasonable efforts to credit sources where appropriate. Kapitales Research does not claim ownership of any third-party media unless explicitly stated otherwise.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au